Home › Cancer (all types) › Georgia › Athens
Cancer (all types) clinical trials in Athens, GA
5 studies for Cancer (all types) are looking for participants at sites in and around Athens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- University Cancer & Blood Center, LLC, Athens
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
RecruitingPhase 2
- University Cancer & Blood Center (UCBC) - Athens, Athens
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 2
- University Cancer & Blood Center, Athens
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
- University Cancer & Blood Center, LLC, Athens
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- University Cancer and Blood Center, Athens
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX124 studies
- New York City, NY105 studies
- Boston, MA90 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Durham, NC61 studies
- Washington, DC60 studies
- Philadelphia, PA57 studies
- Arlington, VA52 studies
- Chicago, IL51 studies
- St. Louis, MO51 studies
- Atlanta, GA49 studies
Other studies in Athens
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer8 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Metastatic Cancer4 studies
- Prostate Cancer4 studies
- Triple-Negative Breast Cancer3 studies
- Melanoma3 studies
- Schizophrenia3 studies
- Psychotic Disorders3 studies
- Colon Cancer3 studies
- Digestive Diseases3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.